Literature DB >> 2552176

A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization.

R Paul1, S Schuetze, S L Kozak, D Kabat.   

Abstract

By using a tagged derivative of Friend spleen focus-forming virus, we previously obtained evidence that proviral integration(s) in the host genome can cause erythroblast immortality by abrogating the commitment of the cell to differentiate (C. Spiro, B. Gliniak, and D. Kabat, J. Virol. 62:4129-4135, 1988). Exploiting the fact that each leukemia was a single clone that contained one tagged provirus, we have now molecularly cloned and characterized one common genomic site for immortalizing proviral integrations.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2552176      PMCID： PMC251145          DOI： 10.1128/JVI.63.11.4958-4961.1989

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  27 in total

1.  A graded-response assay for the Friend leukemia virus.

Authors:  W P ROWE; I BRODSKY
Journal:  J Natl Cancer Inst       Date:  1959-12       Impact factor: 13.506

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

Authors:  C Friend; W Scher; J G Holland; T Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

4.  Cellular origin and role of mink cell focus-forming viruses in murine thymic lymphomas.

Authors:  S K Chattopadhyay; M W Cloyd; D L Linemeyer; M R Lander; E Rands; D R Lowy
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

5.  Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53.

Authors:  J R Jenkins; K Rudge; S Redmond; A Wade-Evans
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

6.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

7.  Emergence of tumorigenic cells during the course of Friend virus leukemias.

Authors:  F Wendling; F Moreau-Gachelin; P Tambourin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

8.  Polycythemia- and anemia-inducing erythroleukemia viruses exhibit differential erythroid transforming effects in vitro.

Authors:  W D Hankins; D Troxler
Journal:  Cell       Date:  1980-12       Impact factor: 41.582

9.  Viral protein expression in producer and nonproducer clones of friend erythroleukemia cell lines.

Authors:  R Anand; F Lilly; S Ruscetti
Journal:  J Virol       Date:  1981-02       Impact factor: 5.103

10.  Friend leukaemia virus-transformed cells, unlike normal stem cells, form spleen colonies in Sl/sld mice.

Authors:  D Mager; T W Mak; A Bernstein
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962
View more
  27 in total

1.  Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease.

Authors:  Daigo Umehara; Shinya Watanabe; Haruyo Ochi; Yukari Anai; Nursarat Ahmed; Mari Kannagi; Charlotte Hanson; Sandra Ruscetti; Kazuo Nishigaki
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Reprogramming leukemia cells to terminal differentiation and growth arrest by RNA interference of PU.1.

Authors:  Michael Papetti; Arthur I Skoultchi
Journal:  Mol Cancer Res       Date:  2007-10       Impact factor: 5.852

3.  The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation.

Authors:  Tanya M Jelacic; Delores Thompson; Charlotte Hanson; Joan L Cmarik; Kazuo Nishigaki; Sandra Ruscetti
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

4.  PU.1 can participate in an active enhancer complex without its transcriptional activation domain.

Authors:  J M Pongubala; M L Atchison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

5.  Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1.

Authors:  Kazuo Nishigaki; Charlotte Hanson; Takashi Ohashi; Angelo Spadaccini; Sandra Ruscetti
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells.

Authors:  Kazuo Nishigaki; Charlotte Hanson; Delores Thompson; Takashi Yugawa; Sandra Ruscetti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.

Authors:  Gordon R Macpherson; Charlotte A Hanson; Delores M Thompson; Christine M Perella; Joan L Cmarik; Sandra K Ruscetti
Journal:  Leuk Res       Date:  2011-09-15       Impact factor: 3.156

9.  The Ets-related transcription factor PU.1 immortalizes erythroblasts.

Authors:  S Schuetze; P E Stenberg; D Kabat
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

10.  Activation of the N-terminally truncated form of the Stk receptor tyrosine kinase Sf-Stk by Friend virus-encoded gp55 is mediated by cysteine residues in the ecotropic domain of gp55 and the extracellular domain of Sf-Stk.

Authors:  Shihan He; Shuang Ni; Shailaja Hegde; Xin Wang; Daniel R Sharda; Avery August; Robert F Paulson; Pamela A Hankey
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.